← All organizations

ImaginAb, Inc.

For profitWebsite ↗

Also known as: ImaginAb, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 31, 2024

Timeline

2000s

Jun 1, 2007
ImaginAb, Inc.— Founded

Drugs by trial phase (10 distinct, 13 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

124i-psca

Indications

Studied for

Recent trials (13)

NCT06218069CollaboratorPhase 2/Phase 3Aug 31, 2024
NCT05744128Lead sponsorPhase 2Feb 16, 2023
NCT05397171CollaboratorPhase 1/Phase 2Jun 7, 2022
NCT05279027CollaboratorEarly Phase 1Mar 8, 2022
NCT04826393CollaboratorPhase 1Dec 31, 2021
NCT05013099Lead sponsorPhase 2Sep 30, 2021
NCT04955262CollaboratorPhase 1Aug 31, 2019
NCT03802123Lead sponsorPhase 2Dec 18, 2018
NCT03107663Lead sponsorPhase 1Apr 1, 2017
NCT02424513Lead sponsorPhase 2Mar 1, 2015
NCT02349022Lead sponsorPhase 2Jan 1, 2015
NCT02092948CollaboratorN/AAug 22, 2013
NCT01923727Lead sponsorPhase 1/Phase 2Aug 1, 2013

Details

Founded: Inglewood, CA, US Jun 1, 2007
Last known activity: Aug 31, 2024